L J Geiter, R J O'Brien. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antitubercular Agents/therapeutic useHumansIsoniazid/therapeutic usePyrazinamide/therapeutic useRifampin/therapeutic useTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/prevention & control
Substances: See more » Antitubercular AgentsPyrazinamideIsoniazidRifampin
Year: 1987 PMID: 3611841 DOI: 10.1093/infdis/156.3.536
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226